Neural tube defects
Active Research Protocols
- 04-C-0055 – Allogeneic HSCT without Preparative Chemotherapy or with Low-Intensity Preparative Chemotherapy using Sirolimus and Sirolimus-Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014